Advertisement
Advertisement
Study decoded · health · detox · Emerging
Wild Mushroom Extract Cuts Inflammatory Marker 64.6% In Immune Cells
64.6% less nitrite, S. luteusIC50 as low as 0.08 mg/mL50.2 mg vitamin C/100gMIC 3.9 mg/mL vs staph
A laboratory study published in Pharmaceuticals on October 3, 2026 found that an extract from wild Suillus luteus mushrooms reduced inflammatory signaling by up to 64.6% in mouse immune cells, while a separate extract from cultivated Agaricus bisporus showed measurable activity against bacteria in lab dishes.
Researchers at a group of Ecuadorian universities analyzed whole mushrooms, caps, and stipes from wild-harvested Suillus luteus and cultivated Agaricus bisporus var. brunnescens, measuring nutrient content and testing extracts in multiple lab systems. A. bisporus whole mushroom and cap contained 46.7 and 50.2 mg per 100 grams of vitamin C, respectively, and between 1,685.9 and 2,152.8 mg per 100 grams dry weight of total phenols, plant compounds with antioxidant activity. S. luteus contained 38,609.0 to 51,974.6 mg per 100 grams dry weight of organic acids, mostly malic acid, and showed higher antioxidant capacity, measured at 3.2 to 3.3 mmol Trolox equivalents per 100 grams by one assay (DPPH) and 4.9 to 5.9 by another (ABTS). In bacterial testing, A. bisporus extract inhibited growth of all eight bacterial strains tested, with its strongest effect against Staphylococcus aureus at a minimum inhibitory concentration of 3.9 mg/mL, but showed no activity against two Candida yeast strains. S. luteus extract killed cancer cells in a dish at concentrations of 0.08 to 0.21 mg/mL (IC50), though the authors reported limited selectivity for tumor cells over healthy cells. In mouse immune cells (macrophages) stimulated to produce inflammatory signals, S. luteus extract reduced nitrite output, a marker of inflammatory activity, by up to 64.6%. Movement changes measured in the roundworm Caenorhabditis elegans, a common lab model for nervous-system effects, were not statistically significant.
This is standard fungal and plant chemistry: compounds like phenols donate electrons to unstable molecules before those molecules damage cells, a mechanism supported broadly in nutrition science rather than something this study newly demonstrated.
Inflammatory Marker Reduction, S. luteus Extract
Data Panel
- Who
- Lab extracts from wild Suillus luteus and cultivated Agaricus bisporus var. brunnescens mushrooms, tested in bacterial cultures, mouse macrophage cells, cancer cell lines, and the roundworm C. elegans; no human or live-animal subjects
- Design
- Laboratory analytical and bioassay study: spectrophotometric and chromatographic composition analysis plus antioxidant (ABTS, DPPH), antimicrobial (microdilution), antiproliferative (MTT), anti-inflammatory (nitrite production in RAW 264.7 macrophages), and C. elegans locomotor assays
- Dose
- Extracts tested across a concentration range; antibacterial MIC as low as 3.9 mg/mL, anticancer IC50 of 0.08 to 0.21 mg/mL, exact locomotor assay concentrations not specified in abstract
- Primary result
- A. bisporus whole mushroom/cap contained 46.7-50.2 mg/100g vitamin C and 1,685.9-2,152.8 mg/100g DW total phenols; S. luteus reduced LPS-induced nitrite (inflammation marker) by up to 64.6% in mouse macrophages
- Secondary
- A. bisporus inhibited growth in all eight bacteria strains tested (MIC 3.9 mg/mL against S. aureus) but showed no activity against two Candida strains; S. luteus showed cancer-cell IC50 of 0.08-0.21 mg/mL with limited tumor selectivity; C. elegans locomotor changes were not statistically significant
- Funding / conflicts
- Funding and conflicts not reported in the abstract
The findings describe isolated extracts in cell culture and a lab worm, not whole mushrooms eaten by people, and no human or live-animal feeding data appear in this record. The cancer-cell result lacked meaningful selectivity for tumor versus normal cells, and the authors describe the entire study as exploratory, a starting point rather than a conclusion. Funding and conflicts were not reported in the abstract.
Dr. Axe's Take
This is lab chemistry, not evidence that eating mushrooms fights infection or cancer in a person. What's useful here is confirmation that Agaricus bisporus, your standard button and cremini mushroom, carries real vitamin C and phenolic antioxidant content, and that Suillus luteus shows strong free-radical-neutralizing capacity from its organic acids along with a notable drop in inflammatory signaling in mouse immune cells. I treat both as reasons to keep cooked mushrooms in regular rotation for fiber, B vitamins and antioxidant compounds, not as an antimicrobial or anticancer strategy. My step this week: add cooked mushrooms several times weekly as part of a whole-food anti-inflammatory pattern, and wait for human trials before expecting more.
— Dr. Axe